In conclusion, we have employed online databases to elucidate the modifications in SIX1 mRNA expression and its correlation with prognosis, ploidy, immune infiltration, gene alteration landscape, mRNA and protein landscape, altered signal pathways of SIX1, and particularly, the biomarkers of cancer stem cells during the development of breast cancer. This evidence concerns the gene SIX1 and breast cancer.